Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls

Alan M. Birch, Sam Groombridge, Robert Law, Andrew G. Leach, Christine D. Mee, Carolin Schramm

Research output: Contribution to journalArticlepeer-review

Abstract

We describe how we have been able to design 4-aminobiphenyls that are nonmutagenic (inactive in the Ames test). No such 4-aminobiphenyls were known to us, but insights provided by quantum mechanical calculations have permitted us to design and synthesize some examples. Importantly, the quantum mechanical calculations could be combined with predictions of other properties of the compounds that contained the 4-aminobiphenyls so that these remained druglike. Having found compounds that are not active, the calculations can provide insight into which factors (electronic and conformational in this case) are important. The calculations provided SAR-like information that was able guide the design of further examples of 4-aminobiphenyls that are not active in the Ames test.
Original languageEnglish
Pages (from-to)3923-3933
Number of pages11
JournalJournal of Medicinal Chemistry
Volume55
Issue number8
DOIs
Publication statusPublished - 26 Apr 2012

Fingerprint

Dive into the research topics of 'Rationally Designing Safer Anilines: The Challenging Case of 4-Aminobiphenyls'. Together they form a unique fingerprint.

Cite this